CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 31 enrolled
Drug / intervention
IR REHAB +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06393088
NCT06393088N/ACompleted

Clinical Trial to Establish the Safety and Efficacy of the invisaRED® IR REHAB Device When Used as an Adjunctive Therapy for Nociceptive Musculoskeletal Pain

IR Technology, LLC·interventional·Posted May 1, 2024·Updated Mar 18, 2025

In Brief

A clinical study evaluating IR REHAB and Sham for Nociceptive Pain and Musculoskeletal Pain. Completed, enrolled 31 participants across 1 site.

Detailed Summary

This is a trial to measure the effectiveness and safety of the invisa-RED® IR REHAB device. The researchers will compare the muscle and joint pain relief of participants who are treated with the real machine, to those treated with a non-working "look-a-like" device. If there is a significant difference of pain relief between those treated with the real machine and those treated with the 'look-a-like' device and no safety issues are discovered, the researchers will be able to assume the IR REHAB device is safe and effective for the treatment of muscle and joint pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedMay 1, 2024
Enrollment StartJul 22, 2024
Primary CompletionAug 30, 2024
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 2.2 years ago

Interventions

IR REHABdevice

Participants undergo therapy sessions with active, dual frequency, low level laser therapy device

Shamdevice

Participants undergo therapy sessions with disabled device producing no laser energy